Sua seleção (0)
Detalhe da pesquisa
1.
The life history of 21 breast cancers.
Cell;
149(5): 994-1007, 2012 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22608083
2.
Pseudouridylation of tRNA-Derived Fragments Steers Translational Control in Stem Cells.
Cell;
173(5): 1204-1216.e26, 2018 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29628141
3.
Mutational processes molding the genomes of 21 breast cancers.
Cell;
149(5): 979-93, 2012 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22608084
4.
Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma.
Clin Cancer Res;
2019 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515461
5.
Clinical protein science in translational medicine targeting malignant melanoma.
Cell Biol Toxicol;
35(4): 293-332, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30900145
6.
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations.
J Med Genet;
2018 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30291219
7.
Prognostic and Chemotherapy Predictive Value of Gene-Expression Phenotypes in Primary Lung Adenocarcinoma.
Clin Cancer Res;
22(1): 218-29, 2016 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26265693
8.
An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
Breast Cancer Res;
18(1): 27, 2016 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26923702
9.
BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition.
Proc Natl Acad Sci U S A;
110(11): 4321-6, 2013 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23447565
10.
CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
Int J Cancer;
137(9): 2220-6, 2015 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25943250
11.
Molecular and genetic diversity in the metastatic process of melanoma.
J Pathol;
233(1): 39-50, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24399611
12.
Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome.
Clin Cancer Res;
20(23): 6127-40, 2014 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25278450
13.
High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.
J Med Genet;
51(8): 545-52, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24935963
14.
A new look at drugs targeting malignant melanoma--an application for mass spectrometry imaging.
Proteomics;
14(17-18): 1963-70, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25044963
15.
Feasibility study on measuring selected proteins in malignant melanoma tissue by SRM quantification.
J Proteome Res;
13(3): 1315-26, 2014 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24490776
16.
WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
Mol Cancer;
13: 88, 2014 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24766647
17.
Inherited variation in the PARP1 gene and survival from melanoma.
Int J Cancer;
135(7): 1625-33, 2014 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24535833
18.
Primary immunodeficiency in infection-prone children in southern Sweden: occurrence, clinical characteristics and immunological findings.
BMC Immunol;
15: 31, 2014 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25318568
19.
Vemurafenib synergizes with nutlin-3 to deplete survivin and suppresses melanoma viability and tumor growth.
Clin Cancer Res;
19(16): 4383-91, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23812671
20.
Molecular profiling reveals low- and high-grade forms of primary melanoma.
Clin Cancer Res;
18(15): 4026-36, 2012 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22675174